-transparent.png){kind=logo}
Characteristics of specific 125I-omega-conotoxin (omega-CgTX) binding were systematically investigated in crude membranes from rat whole brain. Kd and Bmax Values for the binding were 49.7 pM and 181.5 fmol/mg of protein, respectively. The effects of various types of Ca channel antagonists on the binding were investigated. Dynorphin A (1-13), in particular, specifically inhibited 125I-omega-CgTX binding, but not that of [3H](+)PN200-110. Spider venom from Plectreurys tristes did not specifically inhibit specific binding of 125I-omega-CgTX, because the venom also inhibited the binding of [3H](+)PN200-110 to a similar degree. The amount of specific binding of 125I-omega-CgTX was less in the cerebellum than that in any other area of whole brain. The cross-linker disuccinimidyl suberate did not label with 125I-omega-CgTX and its binding sites in rat whole brain, although it did in chick whole brain, which was used as a positive control. These findings suggested that dynorphine A (1-13) was a selective blocker of omega-CgTX-sensitive Ca channels in crude membranes from rat whole brain and that omega-CgTX-sensitive Ca channels were mainly present a rat brain except cerebellum.
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
March 1994,
Brain research. Developmental brain research,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
September 1993,
Neuroreport,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
May 1994,
Neuroreport,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
October 1993,
Neuroscience letters,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
April 1993,
Biochemistry,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
January 1989,
Epilepsia,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
June 1992,
Brain research,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
January 1989,
Neuropeptides,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
November 1987,
Naunyn-Schmiedeberg's archives of pharmacology,
S Ichida, and
T Wada, and
M Sekiguchi, and
H Kishino, and
Y Okazaki, and
T Akimoto
August 1994,
Neuroscience letters,
